Update date
31 Mar 2026
Shareable Research Card
This metric view shows ENZN - Viskase Holdings, Inc. research and development expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported research and development expense: $558,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Mar 2026
Page type
Metric history
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 04 May 2026.
Benchmark Context
Viskase Holdings, Inc. is outside the visible top 120 companies for research and development expense in the current sample.
Compared with
Compared with 120 companies reporting research and development expense in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Research and Development Expense is down about 16% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Plain-English Guide
R&D expense is what the company reports spending on research and development during the period.
Why people care
It helps users understand how heavily the company is investing in future products, platforms, or technology.
How to read it
Compare R&D with revenue and operating income so you can see whether innovation spending is growing faster than the rest of the business.
Compare next
Compare it with revenue, operating income, and capex to understand the mix between current spending and long-term investment.
R&D intensity varies widely by industry, so peer comparisons are most useful when businesses are genuinely comparable.
Open a live SEC-backed example
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: Q1 2026. Period end: 31 Mar 2026. Units: USD. Frequency: quarterly and annual.
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Research and Development Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Which companies spend the most on R&D?
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Meta Platforms, Inc. (meta) | $17,699,000,000 | Quarter - 31 Mar 2026 | Open Meta Platforms, Inc. Research and Development Expense |
| 2 | Alphabet Inc. (googl) | $17,032,000,000 | Quarter - 31 Mar 2026 | Open Alphabet Inc. Research and Development Expense |
| 3 | Merck & Co., Inc. (mrk) | $12,592,000,000 | Quarter - 31 Mar 2026 | Open Merck & Co., Inc. Research and Development Expense |
| 4 | Apple Inc. (aapl) | $11,419,000,000 | Quarter - 28 Mar 2026 | Open Apple Inc. Research and Development Expense |
| 5 | FORD MOTOR CO (f) | $9,400,000,000 | Year - 31 Dec 2025 | Open FORD MOTOR CO Research and Development Expense |
| 6 | MICROSOFT CORP (msft) | $8,915,000,000 | Quarter - 31 Mar 2026 | Open MICROSOFT CORP Research and Development Expense |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 | $558,000 | -$104,000 | -16% | 01 Jan 2026 | 31 Mar 2026 | 10-Q | 04 May 2026 | 2026 | Q1 | |
| Q1 2025 | $662,000 | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 04 May 2026 | 2026 | Q1 | |||
| Q4 2014 | $0 | $0 | -$189,000 | -100% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 05 Mar 2015 | 2014 | FY |
| Q3 2014 | $189,000 | $0 | -$653,000 | -100% | 01 Jul 2014 | 30 Sep 2014 | 10-Q | 06 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $842,000 | $0 | -$294,000 | -100% | 01 Apr 2014 | 30 Jun 2014 | 10-Q | 08 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $1,136,000 | $0 | -$1,579,000 | -100% | 01 Jan 2014 | 31 Mar 2014 | 10-Q | 09 May 2014 | 2014 | Q1 |
| Q4 2013 | $2,715,000 | $189,000 | -$4,162,000 | -96% | 01 Oct 2013 | 31 Dec 2013 | 10-K | 05 Mar 2015 | 2014 | FY |
| Q3 2013 | $6,877,000 | $653,000 | -$3,301,000 | -83% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 06 Nov 2014 | 2014 | Q3 |
| Q2 2013 | $10,178,000 | $294,000 | -$5,379,000 | -95% | 01 Apr 2013 | 30 Jun 2013 | 10-Q | 08 Aug 2014 | 2014 | Q2 |
| Q1 2013 | $15,557,000 | $1,579,000 | -$5,335,000 | -77% | 01 Jan 2013 | 31 Mar 2013 | 10-Q | 09 May 2014 | 2014 | Q1 |
| Q4 2012 | $20,892,000 | $4,351,000 | -$4,784,000 | -52% | 01 Oct 2012 | 31 Dec 2012 | 10-K | 14 Mar 2014 | 2013 | FY |
| Q3 2012 | $25,676,000 | $3,954,000 | -$6,482,000 | -62% | 01 Jul 2012 | 30 Sep 2012 | 10-Q | 12 Nov 2013 | 2013 | Q3 |
| Q2 2012 | $32,158,000 | $5,673,000 | -$4,388,000 | -44% | 01 Apr 2012 | 30 Jun 2012 | 10-Q | 06 Aug 2013 | 2013 | Q2 |
| Q1 2012 | $36,546,000 | $6,914,000 | -$3,634,000 | -34% | 01 Jan 2012 | 31 Mar 2012 | 10-Q | 10 May 2013 | 2013 | Q1 |
| Q4 2011 | $40,180,000 | $9,135,000 | 01 Oct 2011 | 31 Dec 2011 | 10-K | 14 Mar 2014 | 2013 | FY | ||
| Q3 2011 | $10,436,000 | -$3,770,000 | -27% | 01 Jul 2011 | 30 Sep 2011 | 10-Q | 09 Nov 2012 | 2012 | Q3 | |
| Q2 2011 | $10,061,000 | -$70,000 | -0.69% | 01 Apr 2011 | 30 Jun 2011 | 10-Q/A | 21 Aug 2012 | 2012 | Q2 | |
| Q1 2011 | $10,548,000 | 01 Jan 2011 | 31 Mar 2011 | 10-Q | 02 May 2012 | 2012 | Q1 | |||
| Q3 2010 | $14,206,000 | 01 Jul 2010 | 30 Sep 2010 | 10-Q | 04 Nov 2011 | 2011 | Q3 | |||
| Q2 2010 | $10,131,000 | 01 Apr 2010 | 30 Jun 2010 | 10-Q | 05 Aug 2011 | 2011 | Q2 |
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2014 | $0 | -$2,715,000 | -100% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 05 Mar 2015 | 2014 | FY |
| 2013 | $2,715,000 | -$18,177,000 | -87% | 01 Jan 2013 | 31 Dec 2013 | 10-K | 05 Mar 2015 | 2014 | FY |
| 2012 | $20,892,000 | -$19,288,000 | -48% | 01 Jan 2012 | 31 Dec 2012 | 10-K | 14 Mar 2014 | 2013 | FY |
| 2011 | $40,180,000 | -$9,703,000 | -19% | 01 Jan 2011 | 31 Dec 2011 | 10-K | 14 Mar 2014 | 2013 | FY |
| 2010 | $49,883,000 | 01 Jan 2010 | 31 Dec 2010 | 10-K | 18 Mar 2013 | 2012 | FY |